The present invention relates to methods and systems for producing an image of a blood vessel based on a temperature differential determined from information obtained by magnetic resonance imaging.
Angiography is the visualization of blood vessels and can be accomplished with various diagnostic imaging modalities. Conventional x-ray angiography requires injection of iodinated contrast material into a blood vessel through an intra-arterial or intravenous catheter followed by sequential x-ray exposures using conventional film cassettes or digital technology. Conventional x-ray angiography is an invasive procedure and the injection of iodinated contrast material can be associated with adverse reactions including severe allergic reactions and anaphylaxis. Recently, computerized tomography (CT) angiography has begun to replace conventional x-ray angiography. CT angiography has spatial and contrast resolution that is near that of conventional angiography, it is less invasive (only requires an intravenous injection of contrast material) and it allows for multiplanar reconstruction. However, CT angiography still requires the use of x-rays. In addition, because they require iodinated contrast agents, both conventional x-ray angiography and CT angiography cannot be readily repeated. Diagnostic ultrasound with Doppler or color flow imaging can be used to obtain angiographic images of major blood vessels. However, ultrasound angiography has limited spatial resolution, limited depth of penetration into the body and does not readily allow multiplanar reconstruction. In addition, ultrasound angiography cannot visualize the cerebral vasculature,
Magnetic Resonance Angiography (MRA) is a non-invasive technique that does not use ionizing radiation, does not use iodinated contrast material and allows for multiplanar reconstruction. There are two general categories of MRA: contrast enhanced and non-contrast enhanced. Contrast enhanced MRA is performed by imaging after intravenous administration of gadolinium-containing contrast agents. Although these contrast agents are safer than iodinated agents, they still carry the risk of adverse reactions. Contrast enhanced MRA images are obtained during a narrow window of time when the concentration of contrast agent in the vascular space is near its peak and the concentration of contrast agent in the extravascular space is minimal. Advantages of contrast enhanced MRA (compared with non-contrast enhanced MRA) include image signal based on the concentration of contrast agent in the vessel lumen similar to conventional x-ray angiography and CT angiography, higher signal-to-noise ratio and better spatial and contrast resolution. When using gadolinium-based techniques, only a single dose of gadolinium contrast agent can typically be administered at any one time due to safety concerns. In addition, gadolinium contrast agents are expensive. Since the MR signal of contrast enhanced MRA is derived only from the vessel lumen, the vessel wall (or edge) may not be visualized or may be ill-defined. Visualization of the vessel wall may be important for diagnosis of vascular disease, especially small vessel disease, and tracking of vessel wall motion can be used for image gating.
Non-contrast enhanced MRA can be performed using time-of-flight techniques or phase contrast techniques. Time-of-flight techniques rely on the motion of flowing blood to provide signal differences between blood vessels and surrounding soft tissues. Phase contrast techniques rely on motion-induced phase changes in the presence of magnetic field gradients to provide signal differences between blood vessels and surrounding soft tissues. An advantage of the time-of-flight and phase contrast techniques (compared with contrast enhanced techniques) is that they can be performed repeatedly in seconds to minutes without any additional risk. In general however, time-of-flight and phase contrast techniques have lower signal-to-noise and lower spatial resolution than contrast enhanced techniques and, like contrast-enhanced MRA, the edge of blood vessels may not be well-defined. Furthermore, time-of-flight and phase contrast techniques suffer from artifacts related to differences in flow velocity across the lumen of a blood vessel and they do not image blood vessels based on the presence of an intravascular agent.
A need, therefore, exists for an improved MRA technique that provides higher resolution than prior methods, is repeatable, and does not carry the risk of adverse reactions.
Systems and methods of imaging a blood vessel using temperature sensitive MRI are provided. In an embodiment, the present invention provides a method for producing an image of a blood vessel of a patient based on a temperature differential of flowing blood within the vessel determined from information obtained by MRI. The method includes introducing a fluid into a cardiovascular system of the patient and obtaining magnetic resonance information from the blood vessel. The method further includes determining a magnetic resonance parameter in the blood vessel using the magnetic resonance information and determining a temperature differential in the blood vessel using the magnetic resonance parameter. The method further includes producing an image of the blood vessel in which a brightness or a color of pixels therein is based on the temperature differential determined using the magnetic resonance parameter. For example, a threshold temperature differential can be used to display flow in a vessel lumen compared with absence of flow in surrounding tissues using a fixed brightness or fixed color. Alternatively, a temperature differential determined over time can be used to display flow in a vessel lumen such that a brightness or color may reflect both temperature differentials and local flow characteristics.
In an embodiment, the present invention provides a machine-readable medium having stored thereon a plurality of executable instructions, when executed by a processor performs obtaining magnetic resonance information from a blood vessel of a patient after introduction of fluid into a cardiovascular system of the patient and determining a magnetic resonance parameter in the blood vessel using the magnetic resonance information. The plurality of executable instructions further performs determining a temperature differential in the blood vessel using the magnetic resonance parameter and producing an image of the blood vessel in which a brightness or a color of pixels therein is determined by the temperature differential.
In an embodiment, the present invention provides a method for producing an image of a blood vessel of a patient based on a temperature differential of flowing blood within the vessel determined from information obtained by MRI. Specifically, referring to
The blood vessel can be a part of the vasculature of a patient including an artery, vein, capillary or combination thereof. The artery or vein can be a central or peripheral artery or vein. Non-limiting examples of blood vessels include the carotid artery, internal jugular vein, inferior or superior vena cava, aorta, pulmonary artery and vein, illiac artery and vein, femoral artery and vein, popliteal artery and vein, anterior tibial artery and vein, posterior tibial artery and vein, and peroneal artery and vein. Images of a single blood vessel or multiple blood vessels can be obtained according to methods of the present invention.
Referring again to
The fluid can be introduced in any manner such that the fluid can perfuse the blood vessel being imaged and induce temperature changes that can be effectively imaged. For example, the fluid can be injected intravenously or intra-arterially or introduced as a gas in the lungs via inhalation. Further, the fluid can be introduced at a site local or distant to the blood vessel being imaged. For example, the fluid may be injected into a peripheral vein using a conventional intravenous line, into a central vein using a central venous line or through a catheter or needle in a central or peripheral artery that supplies the blood vessel being imaged. The temperature of the introduced fluid can be above or below body temperature. Further, the temperature of the introduced fluid may have a uniform constant temperature below or above body temperature or can vary over time and include temperatures above and below body temperature. For example, the introduced fluid may vary over time when the injection site is remote from the tissue of interest, such as a peripheral vein, and the profile of the injected fluid changes after passing through the heart and pulmonary circulation. Using an injection with a time-varying temperature may reduce such changes. A constant temperature injection may be used, for example, when the injection site is closer to the tissue of interest, such as a central artery, and the profile of the injected fluid does not change as readily.
A system can be used for controlling the temperature of the fluid that is introduced into the patient by combining fluids having two different temperatures and introducing the combined fluid into the patient. Referring to
In this embodiment, system 110 further comprises first reservoir temperature sensor 170 in communication with first reservoir 120 and first line temperature sensor 175 in communication with first fluid line 125. System 110 further comprises second reservoir temperature sensor 180 in communication with second reservoir 130 and second line temperature sensor 185 in communication with second fluid line 135. System 110 further comprises third reservoir temperature sensor 280 in communication with third reservoir 220 and fourth reservoir temperature sensor 270 in communication with fourth reservoir 230. In addition, system 110 comprises convergent line temperature sensors 190 and 290. System 110 further comprises controller 160 for controlling the flow of first, second, third and fourth fluids from respective first, second, third and fourth reservoirs 120, 130, 220, and 230 . Specifically, in an embodiment, controller 160 is in communication with sensors 170, 180, 175, 185, 190, 270, 280 and 290. Controller 160 is also in communication with first pump 200, second pump 210, third pump 240 and fourth pump 250 which, in turn, are in communication with first fluid line 125, second fluid line 135, third fluid line 225 and fourth fluid line 235, respectively. A non-limiting example of first, second, third and fourth pumps 200, 210, 240 and 250 are power injectors. In certain embodiments, a system does not include third and fourth pumps. In certain embodiments, a system does not include a third and fourth pump. In order to control the flow of first and second fluids, controller 160 receives temperature input signals from sensors 170, 180, 175, and 185 regarding the temperature of the first and second fluids and accordingly sends out a control signal to pumps 200 and 210 to adjust the flow rate of the fluids. Likewise, in order to control the flow of third and fourth fluids, controller 160 receives temperature input signals from sensors 280 and 270 regarding the temperature of the third and fourth fluids and accordingly sends out a control signal to pumps 240 and 250 to adjust the flow rate of the fluids. Controller 160 may be computerized and the flow rate of first and second fluids exiting respective first and second reservoirs 120 and 130 can be varied in accordance, for example, with a look-up table or an algorithm to achieve a desired temperature variation of the introduced combined fluid. Temperature readings from the convergent line temperature sensors 190 and 290 can be used to confirm the expected temperature in convergent line 140 as determined, for example, from the look-up table or the algorithm. Controller 160 may be computerized and may introduce additional fluid from third and fourth reservoirs 220 and 230 in accordance, for example, with a look-up table or an algorithm to make adjustments to achieve the desired temperature variation of the introduced fluid or to optimize or adjust the leading and trailing edges of the introduced fluid. In one variation of the algorithm used to achieve a desired temperature variation of the fluid, repetitive injections of the fluid can be made and the algorithm adjusted accordingly.
Referring back to
The magnetic resonance information obtained in 20 is used to determine a magnetic resonance parameter in the blood vessel (30) according to an embodiment of a method of the present invention. Specifically, a magnetic resonance parameter of the blood of the blood vessel is determined Non-limiting examples of magnetic resonance parameters includes phase changes resulting from changes in water proton resonance frequency; changes in TI relaxation time; changes in diffusion coefficients; phase changes as determined by analysis of spectroscopic data; and any combination thereof. Methods for calculating such magnetic resonance parameters involve using well-known mathematical formulas based on the pulse sequence used and the specific parameter that is to be calculated. Methods of the present invention include measuring a single magnetic resonance parameter or multiple magnetic resonance parameters. The magnetic resonance parameter can be calculated on a voxel-by-voxel basis for each slice, series of slices or volume.
The magnetic resonance parameter determined in 30 is used to determine a temperature differential in the blood vessel (40) according to an embodiment of a method of the present invention. Specifically, a temperature differential in blood in the blood vessel is determined. Methods for calculating a temperature differential based on the above-identified magnetic resonance parameters are well-known in the art. For example, if the magnetic resonance parameter is phase changes corresponding to changes in water proton resonance frequency, a corresponding temperature differential can be calculated in accordance with the equation ΔT=Δφ(T)/αγTEB0, where α is a temperature dependent water chemical shift in ppm (parts per million) per C0, γ is the gyromagnetic ratio of hydrogen, TE is the echo time; B0 is the strength of the main magnetic field; and Δφ is phase change.
With respect to calculating a temperature differential based on changes in T1 relaxation time, changes in diffusion coefficients, or phase changes as determined by analysis of spectroscopic data such calculations can be performed, for example, in accordance with the methods described by Quesson and Kuroda (e.g. B Quesson, J A de Zwart & C T W Moonen. “Magnetic Resonance Temperature Imaging for Guidance of Thermotherapy;” 12 J Mag Res Img 525 (2000); K Kuroda, RV Mulkem, K Oshio et al. “Temperature Mapping using the Water Proton Chemical Shift; Self-referenced Method with Echo-planar Spectroscopic Imaging;” 43 Magn Reson Med 220 (2000), both of which are incorporated by reference herein. Of course, as one skilled in the art will appreciate, other methods could also be employed. Notwithstanding which magnetic resonance parameter is used to calculate a temperature differential, the measured temperature change in a voxel will correspond to the concentration of indicator (in this case heat or cold) within the voxel over time.
The temperature differential in the blood vessel is used to produce an image of the blood vessel in which a brightness or a color of pixels therein is determined by the temperature differential (50). Specifically, an image of the blood of a blood vessel is produced. Such an image can be produced by display systems following methods well-known in the art, such as the method described by C Warmuth, M Gunther & C Zimmer; “Quantification of Blood Flow in Brain Tumors: Comparison of Arterial Spin Labeling and Dynamic Susceptibility weighted Contrast-enhanced MR Imaging;” 228 Radiology 523 (2003), for example, which is incorporated by reference herein. For example, an image can be reconstructed such that the brightness of pixels in the image is determined by the magnitude of the temperature differential in the corresponding voxel. A single image or multiple images can be produced according to methods of the present invention. Images may be obtained in an axial plane, a sagittal plane, a coronal plane, an oblique plane or any combination thereof. In one example, a threshold temperature differential can be used to display flow in a vessel lumen compared with absence of flow in surrounding tissues using a fixed brightness or fixed color. In a second example, a temperature differential determined over time can be used to display flow in a vessel lumen such that a brightness or color may reflect both temperature differentials and local flow characteristics.
In another embodiment, the present invention provides a machine-readable medium having stored thereon a plurality of executable instructions, when executed by a processor, performs obtaining magnetic resonance information from a blood vessel of a patient after introduction of fluid into a cardiovascular system of the patient. The plurality of executable instructions further performs determining a magnetic resonance parameter in the blood vessel using the magnetic resonance information, determining a temperature differential in the blood vessel using the magnetic resonance parameter and producing an image of the blood vessel in which a brightness or a color of pixels is determined by the temperature differential. Referring to
Referring to
Referring again to
User computing device 300 and server 420 may implement any operating system, such as Windows or UNIX. Client software 350 and server software 430 may be written in any programming language, such as ABAP, C, C++, Java or Visual Basic
The foregoing description has been set forth merely to illustrate the invention and are not intended as being limiting. Each of the disclosed aspects and embodiments of the present invention may be considered individually or in combination with other aspects, embodiments, and variations of the invention. In addition, unless otherwise specified, none of the steps of the methods of the present invention are confined to any particular order of performance. Modifications of the disclosed embodiments incorporating the spirit and substance of the invention may occur to persons skilled in the art and such modifications are within the scope of the present invention. Furthermore, all references cited herein are incorporated by reference in their entirety.
The present application claims the benefit of and priority to International Patent Application No. PCT/US07/02032, filed 22 Jan. 2007, which claims the benefit of and priority to U.S. Provisional Patent Application No. 60/761,773, filed 25 Jan. 2006, both of which are expressly incorporated herein in their entireties by reference thereto. The present application is related to co-pending applications “Systems and Methods for Determining a Cardiovascular Parameter Using Temperature Sensitive Magnetic Resonance Imaging,” filed herewith and “Systems and Methods for Determining Metabolic Rate Using Temperature Sensitive Magnetic Resonance. Imaging,” filed herewith. Both applications are incorporated by reference herein.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US07/02032 | 1/22/2007 | WO | 00 | 6/9/2010 |
Number | Date | Country | |
---|---|---|---|
60761773 | Jan 2006 | US |